Mankind Pharma Limited (INR) Headquartered in New Delhi, India, Mankind Pharma Limited is a prominent developer, manufacturer, and marketer of pharmaceutical formulations and consumer healthcare products. The company's primary focus is on the Indian market, though it also boasts an international reach. Its extensive pharmaceutical portfolio addresses a broad spectrum of acute and chronic therapeutic areas, encompassing anti-infectives, cardiovascular and gastrointestinal health, anti-diabetic treatments, dermatology, pain management, neurological and CNS disorders, vitamin/mineral/nutrient supplements, and respiratory conditions. Complementing its pharmaceutical offerings, Mankind Pharma provides a variety of consumer healthcare essentials, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, dietary supplements, and anti-acne preparations. These popular products are primarily marketed under recognized brand names such as Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Beyond its core business, the company is involved in the trading and exporting of pharmaceutical and healthcare items, manufacturing packing materials, Ayurvedic products, bulk drugs, and consumer goods. Its diverse operations further extend into real estate, leasing, hospitality, and IT services. Mankind Pharma Limited was established in 1986.

Mankind Pharma Limited (INR) Active

262, Okhla Industrial Estate, New Delhi, DE, IN, 110 020

Stock Price INR

Price Change

Last Dividend INR

Latest Rating

MANKIND.BO's stock peer is ALKEM.BO (Alkem Laboratories Limited)

MANKIND.BO's stock peer is ALKEM.NS (Alkem Laboratories Limited)

MANKIND.BO's stock peer is DRREDDY.BO (Dr. Reddy's Laboratories Limited)

MANKIND.BO's stock peer is DRREDDY.NS (Dr. Reddy's Laboratories Limited)

MANKIND.BO's stock peer is LUPIN.BO (Lupin Limited)

MANKIND.BO's stock peer is LUPIN.NS (Lupin Limited)

MANKIND.BO's stock peer is TORNTPHARM.BO (Torrent Pharmaceuticals Limited)

MANKIND.BO's stock peer is TORNTPHARM.NS (Torrent Pharmaceuticals Limited)

MANKIND.BO's stock peer is ZYDUSLIFE.BO (Zydus Lifesciences Limited)

MANKIND.BO's stock peer is ZYDUSLIFE.NS (Zydus Lifesciences Limited)

Healthcare Drug Manufacturers - Specialty & Generic

Headquartered in New Delhi, India, Mankind Pharma Limited is a prominent developer, manufacturer, and marketer of pharmaceutical formulations and consumer healthcare products. The company's primary focus is on the Indian market, though it also boasts an international reach. Its extensive pharmaceutical portfolio addresses a broad spectrum of acute and chronic therapeutic areas, encompassing anti-infectives, cardiovascular and gastrointestinal health, anti-diabetic treatments, dermatology, pain management, neurological and CNS disorders, vitamin/mineral/nutrient supplements, and respiratory conditions. Complementing its pharmaceutical offerings, Mankind Pharma provides a variety of consumer healthcare essentials, including condoms, pregnancy detection kits, emergency contraceptives, antacid powders, dietary supplements, and anti-acne preparations. These popular products are primarily marketed under recognized brand names such as Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar. Beyond its core business, the company is involved in the trading and exporting of pharmaceutical and healthcare items, manufacturing packing materials, Ayurvedic products, bulk drugs, and consumer goods. Its diverse operations further extend into real estate, leasing, hospitality, and IT services. Mankind Pharma Limited was established in 1986.

60%

Dcf Rating

80%

Return On Equity

80%

Return On Assets

40%

Debt To Equity

20%

Price To Earnings

40%

Price To Book

Dividend Stats Yield is calculated via trailing-12-month period

Ex-Dividend	Payment Date	Dividend	Yield	Dividend Frequency
Dividend Data Not Exist

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions